A randomised trial of progesterone prophylaxis after midtrimester amniocentesis.
Midtrimester amniocentesis to investigate fetal karyotype carries a small risk of fetal loss. To test the hypothesis that progesterone prophylaxis may reduce this. A randomised controlled trial comparing a short prophylactic treatment with progesterone after amniocentesis with untreated controls. There were no differences in frequency of miscarriage, preterm delivery or neonatal outcome. Prophylactic progesterone treatment after amniocentesis does not improve obstetric outcome.